Publication | Closed Access

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

OncologySequencingTumor HeterogeneityClinical UtilityMedicinePathologyCancer GenomicsBronchial NeoplasmMolecular DiagnosticsRadiation OncologyLung CancerHealth Sciences